|
FOR
IMMEDIATE RELEASE
August
11, 2003
At
Drug Discovery Technology 2003, Guava Technologies, Inc. today introduced
the Guava ViaCount RCS assay, a new software option for the Guava
PCA and Guava PCA-96 systems that fully automates data analysis
for cell counting and viability testing.
Fully
automated data analysis for cell counting and viability testing
..
At
Drug Discovery Technology 2003, Guava Technologies, Inc. today introduced
the Guava ViaCount RCS assay, a new software option for the Guava
PCA and Guava PCA-96 systems that fully automates data analysis
for cell counting and viability testing.
The
new Guava RCS software automatically identifies populations of live
and dead cells, while ignoring any debris present in the sample,
without user intervention. Sophisticated clustering algorithms and
heuristics developed using a range of real-world data provide a
standardised, fully automated approach to cell counting and viability
assessment that eliminates user subjectivity in data analysis, increasing
system ease-of-use.
Building
upon the proven Guava ViaCount assay that set new standards by enabling
researchers to quickly and easily distinguish between healthy cells,
apoptotic (dying) cells and those already dead, the new Guava ViaCount
RCS offers an option for research laboratories and cell processing
facilities willing to trade the ability to look at apoptosis for
even greater ease-of-use and standardisation of cell viability measurements
between users.
"Although
we are initially applying Guava RCS to our ViaCount cell count and
viability assay, we expect to leverage this exciting new software
technology, incorporating it into other existing and future Guava
assays, said Paul Kinnon, VP of sales and marketing. "This
strategy supports our overall objective of providing tools to accelerate
life science research, by enabling immediate access to sophisticated
biological assays, at the lab benchtop."
Guava
RCS software allows multiparameter data to be analysed simultaneously
as correlated information rather than researchers interpreting such
data in single parameter histograms with dual parameter plots. The
subjective 2-dimensional plot analysis by researchers is inherently
limited and imprecise because the data cannot be considered in a
correlated fashion.
The
Guava PCA systems, available in both single tube and 96-well plate
formats, simplify cell analysis in a single, powerful benchtop platform
that scientists in the lab can use with less than one day of training.
The Guava PCA systems require only a few microliters of sample volume,
saving precious and expensive cells, reagents and compounds, and
are flexible, highly affordable, and ultra-compact. Unlike traditional
cell analysis systems, the Guava PCA systems produce reliable, objective
single-cell analysis from a single well or tube right at the benchtop.
This gives researchers comprehensive test results-fast-thus streamlining
the entire R&D and drug discovery process.
CONTACTS:
|